Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days. (21st February 2022)
- Record Type:
- Journal Article
- Title:
- Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days. (21st February 2022)
- Main Title:
- Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days
- Authors:
- Low, Mitchell
Singh, Simi
Venkataya, Beatrice
Pearson, Jarryd
Ibrahim, Martha
Jarouche, Mariam
Khoo, Cheang
Rowe, James
Li, Chun G. - Abstract:
- Abstract: Background: Omeprazole is a commonly prescribed proton pump inhibitor that acts to reduce gastric acid secretion. Liquid suspensions are preferred for paediatrics or patients with difficulty swallowing, however, are unstable. Aim: This study reports on the stability of USP‐grade omeprazole, raw powder at 2, 5 and 10 mg/mL dosages suspended in Oral Mix Dry Alka SF (OMSF) stored at 4°C for 70 days. Method: The omeprazole concentration in the suspensions were determined at the time of preparation and at 7, 14, 28, 42, 56 and 70 days by high performance liquid chromatography with photodiode array detection (HPLC‐PDA). The pH, homogeneity, colour, odour, and microbial levels were also determined. Results: All the preparations are stable at 4°C for 70 days, with omeprazole concentration remaining within ±10% of the initial concentration. The pH showed a gradual decline from 9.0 to 7.7 over the study which is an acceptable change. The preparations passed microbial testing up to 70 days. Conclusion: The 70 days stability achieved in OMSF far exceeds the 28 day beyond‐use‐date recommended by the Australian Pharmaceutical Formulary. The OMSF base provides compounding pharmacists with a convenient method to prepare omeprazole suspensions over a wide range of concentrations with extended dating, providing added convenience for the consumer and pharmacists.
- Is Part Of:
- Journal of pharmacy practice and research. Volume 52:Number 1(2022)
- Journal:
- Journal of pharmacy practice and research
- Issue:
- Volume 52:Number 1(2022)
- Issue Display:
- Volume 52, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 1
- Issue Sort Value:
- 2022-0052-0001-0000
- Page Start:
- 34
- Page End:
- 41
- Publication Date:
- 2022-02-21
- Subjects:
- omeprazole -- stability -- suspension vehicle -- oral‐mix -- proton pump inhibitor
Hospital pharmacies -- Australia -- Periodicals
Pharmacy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://jppr.shpa.org.au/Current-issue ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2055-2335 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jppr.1782 ↗
- Languages:
- English
- ISSNs:
- 1445-937X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5034.021000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21030.xml